Concepedia

Kelly E. Dooley

KE

90

Publications

4.8K

Citations

37

H-Index

2002

Active since

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

University of Cape Town

University of California, San Francisco

Stellenbosch University

Kelly E. Dooley is an author at Johns Hopkins University specializing in medicine, tuberculosis, and drug resistance.

ORCID

Top concepts

Publications per year

2002–2024

90

Publications

90

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova et al. · New England Journal of Medicine · 2021 · 521 citations · Full text

Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis

Kelly E. Dooley · American Journal of Tropical Medicine and Hygiene · 2009 · 263 citations · Full text

, , +17

Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin

Kelly E. Dooley, Patrick Sayre, Julie Borland et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 191 citations

Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco

Kelly E. Dooley, Ouafae Lahlou, Ghali Iraqi et al. · BMC Public Health · 2011 · 150 citations · Full text

Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

Beth Williamson, Kelly E. Dooley, Yuan Zhang et al. · Antimicrobial Agents and Chemotherapy · 2013 · 132 citations · Full text

Rows per page

1–5 of 90